An addiction psychiatrist, Dr. Gastfriend has held clinical, research, technology development, and policy roles. At Harvard, he directed Massachusetts General Hospital’s Addiction Research Program. As VP at Alkermes, he directed scientific communications on Vivitrol. His research led most U.S. states to endorse the American Society of Addiction Medicine (ASAM) Criteria. His 150 publications include The ASAM Criteria and Addiction Treatment Matching. His ASAM Criteria CONTINUUM® software is being adopted nationwide. He has consulted to the governments of Belgium, China, Iceland, Israel, Norway, Russia, and the US.
David Gastfriend, M.D.
—
by